Journal of Clinical Investigation · 1993 · 157 citations · 22 references
Life SciencesBiochemistryImmunologyAutoimmunityEnzymologyImmunopathologyAntibody CharacterizationAutoantibodiesAutoantigensAutoimmune Disease PathogenesisAutoimmune DiseasesEnzyme InhibitionAminoacyl-transfer Rna SynthetasesAminoacyl-trna SynthetasesAutoimmune MyositisEnzyme ActivityMyositis-associated AutoantibodiesMyositis-specific AutoantibodiesPathogenic AutoantibodiesReactivity
Autoantibodies to five aminoacyl-tRNA synthetases have been reported, and all have been associated with a syndrome of myositis and interstitial lung disease. Four of these synthetases exist free in the cytoplasm, but the fifth, isoleucyl-tRNA synthetase (recognized by anti-OJ autoantibodies), is a component of the multi-enzyme complex containing at least seven synthetases. In an effort to better understand the origins of these antibodies, we examined sera from 11 patients with anti-OJ autoantibodies for evidence of reaction with other components of the complex. All sera showed a characteristic pattern of 10 proteins bands by immunoprecipitation from HeLa cell extract. 10 of 11 sera significantly inhibited isoleucyl-tRNA synthetase enzyme activity. Serum and IgG from four patients also inhibited leucyl-tRNA synthetase activity, and serum and IgG from two inhibited lysyl-tRNA synthetase. Immunoblotting experiments supported reaction of the two sera with lysyl-tRNA synthetase, and revealed additional reactivity of three sera with a 160-kD component believed to be glutaminyl-tRNA synthetase. Despite reaction of some sera with additional synthetases, the immunoprecipitated tRNA appeared the same with all sera, and functioned as tRNA(ile). While reaction with more than one synthetase was seen with some anti-OJ sera, all synthetases targeted by anti-OJ sera were components of the complex, rather than unassociated synthetases. These findings suggest that an initial autoantibody response against isoleucyl-tRNA synthetase was followed by extension to involve other components of the synthetase complex. These observations may have implications for understanding the generation of antisynthetase autoantibodies.
22
A New Approach to the Classification of Idiopathic Inflammatory Myopathy
Lori A. Love, Richard L. Leff, D. D. Fraser et al. · Medicine · 1991 · 973 citations
Anti-Jo-1 antibody: a marker for myositis with interstitial lung disease.
Robert M. Bernstein, Stephen H. Morgan, Jeffrey T. Chapman et al. · BMJ · 1984 · 549 citations · Full text